Patient-reported outcomes and the FDA Patient-Focused Drug Development Guidance
The Effective Statistician - in association with PSI
00:00
Guidance One
In terms of these different guidances, were are we at the moment? Yes, as i mentioned, in the f start ad the process in 20 70. And they did put us is time line that these guidances should have been finished by the end of last year. In total, i imagine the glaval pandemic, you know, has changed time lines. As a as of to day, and guidance one had already been finalized. Guidance threea four are still sitting on their web on the f,. Although public discussion meetings for these happen back in 20 19.
Transcript
Play full episode
